210 related articles for article (PubMed ID: 24487044)
1. Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?
Losina E; Burbine SA; Suter LG; Hunter DJ; Solomon DH; Daigle ME; Dervan EE; Jordan JM; Katz JN
Osteoarthritis Cartilage; 2014 Mar; 22(3):415-30. PubMed ID: 24487044
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
Losina E; Daigle ME; Suter LG; Hunter DJ; Solomon DH; Walensky RP; Jordan JM; Burbine SA; Paltiel AD; Katz JN
Osteoarthritis Cartilage; 2013 May; 21(5):655-67. PubMed ID: 23380251
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis.
Losina E; Smith KC; Paltiel AD; Collins JE; Suter LG; Hunter DJ; Katz JN; Messier SP
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):855-864. PubMed ID: 30055077
[TBL] [Abstract][Full Text] [Related]
4. Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.
Losina E; Michl G; Collins JE; Hunter DJ; Jordan JM; Yelin E; Paltiel AD; Katz JN
Osteoarthritis Cartilage; 2016 May; 24(5):776-85. PubMed ID: 26746146
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.
Katz JN; Smith SR; Collins JE; Solomon DH; Jordan JM; Hunter DJ; Suter LG; Yelin E; Paltiel AD; Losina E
Osteoarthritis Cartilage; 2016 Mar; 24(3):409-18. PubMed ID: 26525846
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severity.
Sullivan JK; Huizinga J; Edwards RR; Hunter DJ; Neogi T; Yelin E; Katz JN; Losina E
Osteoarthritis Cartilage; 2021 Jan; 29(1):28-38. PubMed ID: 33171315
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation.
Losina E; Usiskin IM; Smith SR; Sullivan JK; Smith KC; Hunter DJ; Messier SP; Paltiel AD; Katz JN
Osteoarthritis Cartilage; 2018 May; 26(5):641-650. PubMed ID: 29481917
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Community-Based Diet and Exercise for Patients with Knee Osteoarthritis and Obesity or Overweight.
Kopp PT; Yang C; Yang H; Katz JN; Paltiel AD; Hunter DJ; Callahan LF; Mihalko SL; Newman JJ; DeVita P; Loeser RF; Miller GD; Messier SP; Losina E
Arthritis Care Res (Hoboken); 2024 Jul; 76(7):1018-1027. PubMed ID: 38450873
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis.
Smith SR; Katz JN; Collins JE; Solomon DH; Jordan JM; Suter LG; Yelin EH; David Paltiel A; Losina E
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):234-242. PubMed ID: 27111538
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical and economic outcomes of a short-term physical activity program in knee osteoarthritis patients.
Silva GS; Sullivan JK; Katz JN; Messier SP; Hunter DJ; Losina E
Osteoarthritis Cartilage; 2020 Jun; 28(6):735-743. PubMed ID: 32169730
[TBL] [Abstract][Full Text] [Related]
11. Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis.
Lenhard NK; Sullivan JK; Ross EL; Song S; Edwards RR; Hunter DJ; Neogi T; Katz JN; Losina E
Arthritis Care Res (Hoboken); 2022 May; 74(5):776-789. PubMed ID: 33253496
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
13. Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis.
Salmon JH; Rat AC; Charlot-Lambrecht I; Eschard JP; Jolly D; Fautrel B
Pharmacoeconomics; 2018 Nov; 36(11):1321-1331. PubMed ID: 30047014
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP
J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Total Knee Arthroplasty vs Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super-Obese Patients: A Markov Model.
Ponnusamy KE; Vasarhelyi EM; Somerville L; McCalden RW; Marsh JD
J Arthroplasty; 2018 Jul; 33(7S):S32-S38. PubMed ID: 29550168
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Surgical and Nonsurgical Treatments for Unicompartmental Knee Arthritis: A Markov Model.
Kazarian GS; Lonner JH; Maltenfort MG; Ghomrawi HMK; Chen AF
J Bone Joint Surg Am; 2018 Oct; 100(19):1653-1660. PubMed ID: 30277995
[TBL] [Abstract][Full Text] [Related]
17. Defining the Value of Future Research to Identify the Preferred Treatment of Meniscal Tear in the Presence of Knee Osteoarthritis.
Losina E; Dervan EE; Paltiel AD; Dong Y; Wright RJ; Spindler KP; Mandl LA; Jones MH; Marx RG; Safran-Norton CE; Katz JN
PLoS One; 2015; 10(6):e0130256. PubMed ID: 26086246
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement.
Smith KC; Paltiel AD; Yang HY; Collins JE; Katz JN; Losina E
Osteoarthritis Cartilage; 2018 Nov; 26(11):1495-1505. PubMed ID: 30092263
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
[TBL] [Abstract][Full Text] [Related]
20. Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis.
Bensen GP; Rogers AC; Leifer VP; Edwards RR; Neogi T; Kostic AM; Paltiel AD; Collins JE; Hunter DJ; Katz JN; Losina E
Osteoarthritis Cartilage; 2023 Feb; 31(2):279-290. PubMed ID: 36414225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
